EUR HEART J-CARD PHA - European heart journal. Cardiovascular pharmacotherapy

Publications

  1. 2023
  2. Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry

    Becher, P. M., Savarese, G., Benson, L., Dahlström, U., Karlström, P., Mol, P. G. M., Metra, M., Bhatt, D. L., Pitt, B. & Lund, L. H., 02.06.2023, In: EUR HEART J-CARD PHA. 9, 4, p. 343-352 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Antithrombotic therapy following revascularization for chronic limb-threatening ischaemia: a European survey from the ESC Working Group on Aorta and Peripheral Vascular Diseases

    De Carlo, M., Schlager, O., Mazzolai, L., Brodmann, M., Espinola-Klein, C., Staub, D., Aboyans, V., Sillesen, H., Debus, S., Venermo, M., Belch, J., Ferrari, M. & De Caterina, R., 10.04.2023, In: EUR HEART J-CARD PHA. 9, 3, p. 201-207 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2022
  5. Edoxaban for stroke prevention in atrial fibrillation and age-adjusted predictors of clinical outcomes in routine clinical care

    Kirchhof, P., Pecen, L., Bakhai, A., de Asmundis, C., de Groot, J. R., Deharo, J. C., Kelly, P., Levy, P., Lopez-de-Sa, E., Monteiro, P., Steffel, J., Waltenberger, J., Weiss, T. W., Laeis, P., Manu, M. C., Souza, J. & De Caterina, R., 15.12.2022, In: EUR HEART J-CARD PHA. 9, 1, p. 47-57 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial: The XATOA Registry

    Fox, K. A. A., Aboyans, V., Debus, E. S., Zeymer, U., Cowie, M. R., Patel, M., Welsh, R. C., Bosch, J., Gay, A., Vogtländer, K. & Anand, S. S., 02.12.2022, In: EUR HEART J-CARD PHA. 8, 8, p. 825-836 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Anticoagulation in atrial fibrillation and liver disease: a pooled-analysis of > 20000 patients

    Chen, S., Pürerfellner, H., Meyer, C., Sommer, P., Galindo Kiuchi, M., Martinek, M., Futyma, P., Zanchi, S., Zhu, L., Schratter, A., Wang, J., Acou, W-J., Liu, S., Ling, Z., Yin, Y., Ouyang, F., Chun, J. K. R. & Schmidt, B., 08.06.2022, In: EUR HEART J-CARD PHA. 8, 4, p. 336-345 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. Treatment of fabry disease with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS)

    Lenders, M., Nordbeck, P., Kurschat, C., Eveslage, M., Karabul, N., Kaufeld, J., Hennermann, J. B., Patten, M., Cybulla, M., Müntze, J., Üçeyler, N., Liu, D., Das, A. M., Sommer, C., Pogoda, C., Reiermann, S., Duning, T., Gaedeke, J., von Cossel, K., Blaschke, D., Brand, S-M., Alexander Mann, W., Kampmann, C., Muschol, N., Canaan-Kühl, S. & Brand, E., 05.2022, In: EUR HEART J-CARD PHA. 8, 3, p. 272–281

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2021
  10. PharmaPulse: new trial evidence from the HFA/ESC Heart Failure Congress 2021

    Becher, P. M. & Savarese, G., 03.11.2021, In: EUR HEART J-CARD PHA. 7, 6, p. e88

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  11. The relevance of depressive symptoms for the outcome of patients receiving vitamin K-antagonists: Results from the thrombEVAL cohort study

    Michal, M., Eggebrecht, L., Göbel, S., Panova-Noeva, M., Nagler, M., Arnold, N., Lauterbach, M., Bickel, C., Wiltink, J., Beutel, M. E., Münzel, T., Wild, P. S. & Prochaska, J. H., 23.07.2021, In: EUR HEART J-CARD PHA. 7, 4, p. 271-279 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  12. Edoxaban for stroke prevention in atrial fibrillation in routine clinical care: 1-year follow-up of the prospective observational ETNA-AF-Europe study

    de Groot, J. R., Weiss, T. W., Kelly, P., Monteiro, P., Deharo, J. C., de Asmundis, C., López-de-Sá, E., Waltenberger, J., Steffel, J., Levy, P., Bakhai, A., Zierhut, W., Laeis, P., Manu, M. C., Reimitz, P-E., De Caterina, R., Kirchhof, P. & ETNA-AF-Europe investigators, 09.04.2021, In: EUR HEART J-CARD PHA. 7, FI1, p. f30-f39

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. 2019
  14. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis

    Haller, P. M., Sulzgruber, P., Kaufmann, C., Geelhoed, B., Tamargo, J., Wassmann, S., Schnabel, R. B., Westermann, D., Huber, K., Niessner, A. & Gremmel, T., 01.10.2019, In: EUR HEART J-CARD PHA. 5, 4, p. 226-236 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review